The tweet was deleted by the author.
But we saved everything 🙂.
Corteva shares insights into investment strategies focused on field performance in the latest episode of Turnrow Talk.
The discussion covers making input spending more effective and evaluating biological products based on real-world performance and return on investment. Corteva shares a link to the episode for additional information.
CTVA is trading at $77.03, below the MA-20 ($79.91) and MA-50 ($81.09) but well above the MA-200 ($72.67), highlighting short- and medium-term seller pressure while long-term trend support remains intact. The Ichimoku Kijun sits at $80.43, marking immediate resistance, and key support levels are found near MA-100 ($78.37) and MA-200 ($72.67), with MA-50 ($81.09) and Kijun ($80.43) acting as resistance.
Momentum indicators on D1 lean bearish: MACD signals selling pressure and ADX is neutral at 13.62, reflecting weak trend strength. Both RSI (37.53) and CCI (–108.21) register near-oversold levels, while Stoch RSI and BBP confirm sellers dominate in the current session. There is some divergence since weekly ADX and MACD are more constructive. Over the past week, CTVA has fallen $1.26 (1.61%) from a previous close of $78.29, with the current price at the very bottom of the weekly range and volatility at 3.74%. The tone remains one of steady decline toward weekly support.
For the upcoming week, CTVA is expected to trade in a $76.50–$79.60 range, staying above its 52-week low of $60.53 and below its annual high of $85.63. The probability of a price increase is high (more than 80%) given the strong Buy signals from RSI, ADX, and MACD on W1, making a decline less likely. The baseline scenario is for continued sideways trading between $76.50 and $79.60. Bullish momentum would emerge on a break above $79.60, targeting the $80.40 area. A bearish scenario would see the price drop below $76.50, exposing $72.70 as the next key support.
Earlier, analysts noted that Corteva was showing strong bullish momentum, with buyers dominating recent price action despite signals of overbought conditions. The current analysis adds a new dimension by highlighting evolving short-term risks and suggests that monitoring shifts in market sentiment around any key reversals will be crucial for active traders.